Use of Funds Min Subscription $1,995,000 Max Subscription $5,950,000
Amount($) (%) Amount ($) (%)
Existing cash reserves of the Company 5,859,218 (74.6%) 5,859,218 (49.6%)
Production manufacture cost 2,600,000 (33.1%) 3,500,000 (29.6%) Medical research and product development 1,500,000(19.1%) 2,500,000 (21.2%) Hemp business development and marketing 1,150,000 (14.6%) 2,250,000 (19.1%) Exploration and expenditure associated with the Bauxite Projects 100,000(2.5%) 300,000 (2.5%) Costs associated with the recompliance with Chapters 1 & 2 of the ASX Listing Rules 820,750 (6.4%) 860,300 (4.6%) Raw materials for inventory build 1,200,000 (15.3%) 1,500,000 (12.7%) Corporate and administration costs 400,000 (5.1%) 750,000 (6.4%) Balance for working capital 83,468 (3.8%) 148,918 (4.0%)
TOTAL 7,854,218 (100%) 11,809,218 (100%)
Not going to be a lot of coin left. Better hope the revenue train is stopping at CGB station regularly....
CGB Price at posting:
3.7¢ Sentiment: None Disclosure: Held